Zevra Therapeutics Given New 23.00 Price Target at Canaccord Genuity Group
| OBGIX Fund | USD 31.80 0.09 0.28% |
Slightly above 54% of Oberweis Emerging's investor base is interested to short. The analysis of overall sentiment of trading Oberweis Emerging Growth mutual fund suggests that many investors are impartial at this time. Oberweis Emerging's investing sentiment can be driven by a variety of factors including economic data, Oberweis Emerging's earnings reports, geopolitical events, and overall market trends.
Oberweis |
Zevra Therapeutics had its target price decreased by analysts at Canaccord Genuity Group from 25.00 to 23.00 in a report released on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. Canaccord Genuity Groups price objective indicates a potential upside of 166.82 percent from the companys current price.
Read at thelincolnianonline.com
 |
Oberweis Emerging Fundamental Analysis
We analyze Oberweis Emerging's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Oberweis Emerging using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Oberweis Emerging based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Oberweis Emerging is currently under evaluation in number of employees among similar funds. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Oberweis Emerging Growth Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Oberweis Emerging mutual fund to make a market-neutral strategy. Peer analysis of Oberweis Emerging could also be used in its relative valuation, which is a method of valuing Oberweis Emerging by comparing valuation metrics with similar companies.
Peers
Oberweis Emerging Related Equities
| ASTIX | Astor Long/short | 0.14 | ||||
| TSDCX | Touchstone Ultra | 0.11 | ||||
| SUSAX | Siit Ultra | 0.10 | ||||
| OWSBX | Old Westbury | 0.1 | ||||
| CDICX | Calvert Short | 0.06 | ||||
| LCSAX | Locorr Long/short | 0.44 |
Other Information on Investing in Oberweis Mutual Fund
Oberweis Emerging financial ratios help investors to determine whether Oberweis Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oberweis with respect to the benefits of owning Oberweis Emerging security.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |